Wall Street Zen Upgrades Agilent Technologies (NYSE:A) to “Buy”

Agilent Technologies (NYSE:A) was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Sunday.

Several other equities research analysts also recently commented on the stock. Royal Bank Of Canada began coverage on shares of Agilent Technologies in a research note on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 target price on the stock. Jefferies Financial Group started coverage on shares of Agilent Technologies in a research report on Thursday, July 9th. They set a “hold” rating and a $135.00 target price for the company. HSBC cut their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Wolfe Research restated a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Finally, Piper Sandler assumed coverage on shares of Agilent Technologies in a research note on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective on the stock. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $159.35.

Agilent Technologies Price Performance

Shares of Agilent Technologies stock opened at $139.88 on Friday. The firm has a market cap of $39.51 billion, a P/E ratio of 28.09, a price-to-earnings-growth ratio of 2.46 and a beta of 1.25. The firm’s 50-day simple moving average is $132.85 and its 200-day simple moving average is $125.09. Agilent Technologies has a twelve month low of $108.35 and a twelve month high of $160.27. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same quarter in the prior year, the business posted $1.31 earnings per share. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, research analysts expect that Agilent Technologies will post 6.01 EPS for the current fiscal year.

Institutional Trading of Agilent Technologies

Hedge funds and other institutional investors have recently modified their holdings of the stock. BIP Wealth LLC bought a new position in Agilent Technologies in the 2nd quarter valued at $834,000. Everett Harris & Co. CA acquired a new position in shares of Agilent Technologies during the second quarter valued at $202,000. Oppenheimer Asset Management Inc. lifted its stake in shares of Agilent Technologies by 75.9% during the second quarter. Oppenheimer Asset Management Inc. now owns 96,824 shares of the medical research company’s stock valued at $12,861,000 after acquiring an additional 41,794 shares during the period. Jennison Associates LLC lifted its stake in shares of Agilent Technologies by 81.3% during the second quarter. Jennison Associates LLC now owns 621,278 shares of the medical research company’s stock valued at $82,524,000 after acquiring an additional 278,571 shares during the period. Finally, Eurizon SLJ Capital Ltd bought a new position in Agilent Technologies in the second quarter valued at about $10,128,000.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.